Celgene Corp Celg Presents At Morgan Stanley Global Healthcare Conference Call Transcript | Latest News RSS feed

Celgene Corp Celg Presents At Morgan Stanley Global Healthcare Conference Call Transcript - Latest News


Celgene Corp. (CELG) Presents at Morgan Stanley Global Healthcare Conference Call Transcript

Celgene Corp. (NASDAQ:CELG) Morgan Stanley Global Healthcare Conference Call September 14, 2018 11:40 AM ET Executives Nadim Ahmed - President, Hematology & Oncology David Elkins - CFO Analysts ... read more

Morgan Stanley Healthcare Conference

Management on Q4 2016 Results - Earnings Call Transcript Good morning. Welcome to Morgan Stanley's Healthcare Conference. I'm Katy Huberty, Morgan Stanley's IT Hardware Analyst and I'm really pleased ... read more

Biotech Stock Performance Review -- BioCryst Pharma, Celgene, Exelixis, and Geron

Moreover, shares of Celgene, which discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide, have an RSI of 34.72. On October 27 th, 2017, research firm ... read more

Looking for another news?


Celgene Prices $3 Billion of Senior Unsecured Notes

Celgene Corporation (NASDAQ:CELG) today announced the successful pricing ... Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as joint book-running managers ... read more


Celgene (CELG) Management Presents at Morgan Stanley Global Healthcare Unplugged Conference - Brokers Conference Transcript

Celgene Corp (NASDAQ:CELG) Morgan Stanley Global Healthcare Unplugged Conference Call September 12, 2016 2:50 PM ET Executives Scott Smith - President, Global Inflammation and Immunology Analysts ... read more

UTC – United Technologies Corporation: United Technologies To Acquire Rockwell Collins For $30 Billion

4, 2017/PRNewswire/ -- United Technologies Corp ... Stanley & Co. LLC is acting as financial advisor to United Technologies. Wachtell, Lipton, Rosen & Katz is serving as legal advisor to United ... read more

MorphoSys and Celgene Create Strategic Alliance to Advance CD38 Cancer Program MOR202 for Patients with Multiple Myeloma

MorphoSys will hold a public conference call and ... replay and transcript will be made available at http://www.morphosys.com/conference-calls. About Celgene Celgene Corporation, headquartered in ... read more

Healthcare: Is Celgene Going to Buy Juno Therapeutics?

Rumors are swirling that Celgene Corp. (NASDAQ: CELG) may pay billions of dollars to buy Juno Therapeutics (NASDAQ ... I was at the JP Morgan Healthcare Conference in San Francisco. This is the ... read more

Biotech Stock Roundup: Celgene to Acquire Impact, J.P. Morgan Healthcare Conference in Focus

Meanwhile, Celgene CELG was in the news with the company announcing its intention ... Key Takeaways from J.P. Morgan Healthcare Conference: Several biotech companies were present at the 36th annual ... read more

Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes

... date of the offers to exchange (the “Exchange Offers”) notes (the “Celgene Notes”) issued by Celgene Corporation (NASDAQ:CELG) (“Celgene”) for up to $19,850,000,000 aggregate principal amount of ... read more

Should You Buy Celgene Stock?

A trial failure, disappointing long-term guidance, and an embarrassing stumble at the FDA's finish line have erased billions of dollars from Celgene Corp.'s (NASDAQ: CELG) market cap ... I mean, on ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us